Commodore Capital LP - 26 Mar 2026 SCHEDULE 13G Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)
- Filing Manager
- Commodore Capital LP
- Reporting Manager
- Commodore Capital LP
- Symbol
- KPTI
- Shares outstanding
- 19,696,970 shares
- Disclosed Ownership
- 1,950,000 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 02 Apr 2026, 16:26:26 UTC
- Date of event
- 26 Mar 2026
- SEC
- View on sec.gov
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Commodore Capital LP | 9.9% | 1,950,000 | 0 | 1,950,000 | Michael Kramarz | Managing Partner | |
| Commodore Capital Master LP | 9.9% | 1,950,000 | 0 | 1,950,000 | Michael Kramarz | Authorized Signatory | |
| Robert Egen Atkinson | 9.9% | 1,950,000 | 0 | 1,950,000 | Robert Egen Atkinson | Authorized Signatory | |
| Michael Kramarz | 9.9% | 1,950,000 | 0 | 1,950,000 | Michael Kramarz | Authorized Signatory |